If you are
Rh-negative, your red blood cells do not have a marker
called Rh factor on them. Rh-positive blood does have this marker. If your
blood mixes with Rh-positive blood, your
immune system will react to the Rh factor by making
antibodies to destroy it. This immune system response is called Rh
sensitization.
What causes Rh sensitization during pregnancy?
Rh sensitization can occur during pregnancy if you are
Rh-negative and pregnant with an unborn baby (fetus) who has
Rh-positive blood. In most cases, your blood will not mix with your baby's
blood until delivery. It takes a while to make antibodies that can affect the
baby, so during your first pregnancy, the baby probably would not be
affected.
But if you get pregnant again with an Rh-positive baby, the
antibodies already in your blood could attack the baby's red blood cells. This
can cause the baby to have
anemia,
jaundice, or more serious problems. This is called
Rh disease. The problems will tend to get worse with
each Rh-positive pregnancy you have.
During your first pregnancy, your baby could be at risk for Rh
disease if you were sensitized before or during pregnancy. This can happen if:
You had a previous miscarriage, abortion, or
ectopic pregnancy and you did not receive Rh immune
globulin to prevent sensitization.
You had a serious injury to
your belly during pregnancy.
You had a medical test such as an
amniocentesis or
chorionic villus sampling while you were pregnant, and
you did not receive Rh immune globulin. These tests could let your blood and
your baby's blood mix.
Rh sensitization is one reason it's important to see your doctor
in the first trimester of pregnancy. It doesn't cause any warning symptoms, and
a blood test is the only way to know you have it or are at risk for it.
If you are at risk, Rh sensitization can
almost always be prevented.
If you are already sensitized,
treatment can help protect your baby.
Who gets Rh sensitization during pregnancy?
Rh sensitization during pregnancy can only happen if a woman has
Rh-negative blood and only if her unborn baby has Rh-positive blood.
If the mother is Rh-negative and the father
is Rh-positive, there is a good chance the baby will have Rh-positive blood. Rh
sensitization can occur.
If both parents have Rh-negative blood,
the baby will have Rh-negative blood. Since the mother's blood and the baby's
blood match, sensitization will not occur.
If you have Rh-negative blood, your doctor will probably treat
you as though the baby's blood is Rh-positive no matter what the father's blood
type is, just to be on the safe side.
How is Rh sensitization diagnosed?
All pregnant women get a blood test at their first prenatal visit
during early pregnancy. This test will show if you have Rh-negative blood and
if you are Rh-sensitized.
If you have Rh-negative blood but are not
sensitized:
The blood test may be repeated between 24
and 28 weeks of pregnancy. If the test still shows that you are not sensitized,
you probably will not need another antibody test until delivery. (You might
need to have the test again if you have an amniocentesis, if your pregnancy
goes beyond 40 weeks, or if you have a problem such as
placenta abruptio, which could cause bleeding in the
uterus.)
Your baby will have a blood test at birth. If the newborn
has Rh-positive blood, you will have an antibody test to see if you were
sensitized during late pregnancy or childbirth.
If you are Rh-sensitized, your doctor will
watch your pregnancy carefully. You may have:
Regular blood tests, to check the level of
antibodies in your blood.
Doppler ultrasound, to check blood flow to the baby's brain. This can show
anemia and how severe it is.
Amniocentesis after 15 weeks, to
check the baby's blood type and Rh factor and to look for problems.
How is Rh sensitization prevented?
If you have Rh-negative
blood but are not Rh-sensitized, your doctor will give you one or more shots of
Rh immune globulin (such as RhoGAM). This prevents Rh sensitization in about 99
women out of 100 who use it.1
You may get a shot of Rh immune globulin:
If you have a test such as an
amniocentesis.
Around week 28 of your pregnancy.
After delivery if your newborn is Rh-positive.
The shots only work for a short time, so you will need to repeat
this treatment each time you get pregnant. (To prevent sensitization in future
pregnancies, Rh immune globulin is also given when an Rh-negative woman has a
miscarriage, abortion, or ectopic pregnancy.)
The shots won't work if you are already Rh-sensitized.
How is it treated?
If you are Rh-sensitized, you will have regular testing to see
how your unborn baby is doing. You may also need to see a doctor who
specializes in high-risk pregnancies (a perinatologist).
Treatment of the baby is based on how severe the loss of red
blood cells (anemia) is.
If the baby's anemia is mild, you will just
have more testing than usual while you are pregnant. The baby may not need any
special treatment after birth.
If anemia is getting worse, it may
be safest to deliver the baby early. After delivery, some babies need a
blood transfusion or treatment for
jaundice.
For severe anemia, a baby can have a blood transfusion
while still in the uterus. This can help keep the baby healthy until he or she
is mature enough to be delivered. You will most likely have an early
C-section, and the baby may need to have another blood
transfusion right after birth.
In the past, Rh sensitization was often deadly for the baby. But
improved testing and treatment mean that now most babies with Rh disease
survive and do well after birth.
Rh sensitization can occur when a person with
Rh-negative blood is exposed to Rh-positive blood.
About 90% of women who become sensitized do so during childbirth, when their
blood mixes with the Rh-positive blood of their fetus.1 Once exposed, a mother's
immune system produces
antibodies against Rh-positive red blood cells. For
more information about events and procedures that can put you at high risk for
Rh sensitization, see the What Increases Your Risk section of this topic.
The minimum amount of blood mixing necessary to cause sensitization
is not known. However, many women become sensitized during pregnancy or
childbirth after being exposed to as little as
0.1 mL of Rh-positive fetal blood.1, 2 Fortunately, Rh sensitization
can almost always be prevented with the
Rh immune globulin injection.
When an Rh-negative person's immune system is first exposed to
Rh-positive blood, it takes several weeks to develop immunoglobulin M, or IgM,
antibodies. IgM antibodies are too large to cross the
placenta. Therefore, the Rh-positive fetus that first
triggers maternal sensitization is usually not harmed.
A previously Rh-sensitized immune system rapidly reacts to
Rh-positive blood, as during a second pregnancy with an Rh-positive fetus.
Usually within hours of Rh-positive blood exposure, smaller immunoglobulin G,
or IgG, antibodies are formed. IgG antibodies can cross the placenta and
destroy fetal red blood cells. This causes
Rh disease, which is dangerous for the fetus.
Some Rh-negative people never become sensitized, even after
exposure to large amounts of Rh-positive blood. The reason for this is not
known.
Symptoms
If you are already
Rh-sensitized or become Rh-sensitized while pregnant,
you will not have any unusual symptoms.
Fetal problems from Rh sensitization are detected with
Doppler ultrasound testing and sometimes with
amniocentesis. It is possible, however, that a fetus
with severe Rh disease will move less frequently than it did earlier in the
pregnancy.
If you have been Rh-sensitized in the past, you must be closely
monitored during any pregnancy with an Rh-positive partner because
your fetus is more likely to have Rh-positive blood. In response to an
Rh-positive fetus, your immune system may quickly develop IgG antibodies, which
can cross the placenta and destroy fetal red blood cells. Each subsequent
pregnancy with an Rh-positive fetus may produce more serious problems for the
fetus. The resulting fetal disease (called Rh disease,
hemolytic disease of the newborn, or erythroblastosis
fetalis) can be mild to severe.
Mild Rh disease involves limited destruction
of fetal red blood cells, possibly resulting in mild fetal
anemia. The fetus can usually be carried to term and
requires no special treatment but may have problems with
jaundice after birth. Mild Rh disease is more likely
to develop in the first pregnancy after sensitization has
occurred.
Moderate Rh disease involves the destruction of larger
numbers of fetal red blood cells. The fetus may develop an enlarged
liver and may become moderately anemic. The fetus may
need to be delivered before term and may require a blood transfusion before
(while in the uterus) or after birth. A newborn with moderate Rh disease is
watched closely for jaundice.
Severe Rh disease (fetal hydrops) involves widespread destruction of
fetal red blood cells. The fetus develops severe anemia, liver and
spleen enlargement, increased
bilirubin levels, and fluid retention (edema). The
fetus may need one or more blood transfusions before birth. A fetus with severe
Rh disease who survives the pregnancy may need a blood exchange. This procedure
replaces most of the infant's blood with donor blood (usually type O,
Rh-negative).
A history of pregnancy with Rh disease is a sign that
you will need special treatment when you are pregnant with an Rh-positive
fetus.
If you have been Rh-sensitized in the past, an Rh-negative fetus
cannot trigger an immune reaction.
What Increases Your Risk
Rh sensitization can occur when a person with
Rh-negative blood is exposed to Rh-positive blood.
During pregnancy, an Rh-negative woman can become
sensitized if she is carrying an Rh-positive
fetus.
Factors that increase the risk of blood mixing and sensitization
during pregnancy include:3
Miscarriage (spontaneous abortion),
ectopic pregnancy, or elective abortion (medical or
surgical abortion) after 8 weeks of fetal age (when fetal blood cell production
begins).
Although rare, Rh sensitization has been known to occur after
needle sharing between intravenous drug users. Transfusing Rh-positive blood in
an Rh-negative person can also trigger sensitization; however, this is
extremely rare because blood is always tested prior to transfusion.
When To Call a Doctor
If you are already Rh-sensitized and are pregnant
Your pregnancy will be closely monitored. Discuss possible
symptoms early in pregnancy with your health professional. Repeated diagnostic
testing will be necessary to monitor the fetus.
Call your health professional immediately
if you note a decrease in your fetus's movement after 24 to 26 weeks of
pregnancy.
If you are Rh-negative
Call your health professional immediately
if you:
Think you may have been pregnant and
miscarried.
Are pregnant and have had an accident that may have
injured your abdomen.
Regular prenatal visits are essential. You will need an Rh immune
globulin shot at 24 to 28 weeks and again after delivery if your baby has
Rh-positive blood. This is the only way you can prevent
Rh sensitization.
Watchful Waiting
Watchful waiting is not appropriate for Rh sensitization. It is
important to keep all prenatal appointments so that your developing fetus can
be closely monitored throughout your pregnancy.
Who To See
A woman who may have problems with
Rh incompatibility or sensitization can be treated
by:
If you test positive for Rh sensitization, your health care
system or health professional may want you to be followed and treated by a
perinatologist or an obstetrician who can easily call in a
perinatologist.
If you are pregnant, you will have your first prenatal tests during
your first
trimester. At your first prenatal visit, every woman
has her blood tested to see what her blood type is. If your blood is
Rh-negative, it will also be tested for
antibodies to Rh-positive blood. If you have
antibodies, that means that you have been
sensitized to Rh-positive blood. The antibodies can
now kill Rh-positive red blood cells.
If you are pregnant or have
miscarried, or if you have had an elective abortion, a
partial molar pregnancy, or an
ectopic pregnancy, you will need testing to see if you
have been sensitized to Rh-positive blood.
At the first prenatal visit, your blood is
tested to see if you have been previously sensitized to Rh-positive blood. If
you are Rh-negative and test results show that you are not sensitized, a repeat
test may be done between 24 and 28 weeks.
If test results at 28
weeks show that you have not been sensitized, no additional tests for
Rh-related problems are done until delivery (barring complications such as
placenta abruptio). You will also have a shot of Rh
immune globulin. This lowers your chances of being sensitized during the last
weeks of your pregnancy.
If your newborn is found to be
Rh-positive, your blood will be screened again at delivery with an indirect
Coombs' test to see if you have been sensitized during late pregnancy or
childbirth. If you have not been sensitized, you will have another shot of Rh
immune globulin.
If you are sensitized to the Rh factor
If you are already Rh-sensitized or become sensitized while
pregnant, close monitoring is important to determine whether your fetus is
being harmed.
An
indirect Coombs' test is done periodically during your
pregnancy to see if your Rh-positive antibody levels are increasing. This is
the typical course of treatment for most sensitized women during
pregnancy.
Fetal
Doppler ultrasound of blood flow in the brain shows
fetal anemia and how bad it is. At a medical center with Doppler experts, this
test can give you the same anemia information as
amniocentesis, without the risks.4
On a repeated
basis to check fetal anemia. This tells how much a fetus is being affected by
sensitization.
Fetal blood sampling (cordocentesis) may be done to
directly assess your fetus's health. This procedure is used on a limited basis,
usually for monitoring known sensitization problems (as when a mother has had
previous fetal deaths, or when other testing has shown signs of fetal
distress).
Electronic fetal heart monitoring
(nonstress test) may be done in the third trimester to check your fetus's
condition. Unusual fetal heart rhythms detected during a nonstress test may be
a sign that the fetus has
anemia related to the sensitization.
Fetal ultrasound testing can be used as a pregnancy
progresses to detect sensitization problems, such as fetal fluid retention (a
sign of severe Rh disease).
Early Detection
Early prenatal Rh blood typing and testing for Rh sensitization
is necessary to ensure that every vulnerable fetus can be properly monitored
and treated.
Treatment Overview
If you are sensitized to the Rh factor
If your blood is Rh-negative and you have been
sensitized to Rh-positive blood, you now have
antibodies to Rh-positive blood. The antibodies kill
Rh-positive red blood cells. If you become pregnant with an Rh-positive baby
(fetus), the antibodies can destroy your fetus's red blood cells. This can
cause
anemia.
If you are already Rh-sensitized and are pregnant, your treatment
will focus on preventing or minimizing fetal harm and on avoiding early
(preterm) delivery.
Treatment options depend on how well or poorly the fetus is
doing.
If possible, the father will be tested to see
if the fetus could be Rh-positive. If the father is Rh-negative, the fetus is
Rh-negative and is not in danger. If the father is Rh-positive,
amniocentesis will probably be used to learn the
fetus's blood type. In some medical centers, the mother's blood can be tested
to learn her fetus's blood type. This is a new test that is not widely
available.
If testing shows that your fetus Rh-positive but is only
mildly affected by your Rh factor antibodies, you will be closely monitored
until your pregnancy reaches term. Your fetus will be delivered early only if
his or her condition worsens.
If testing shows that your fetus is
moderately affected by your Rh antibodies, your fetus's condition will be
closely monitored until his or her lungs are mature enough for a preterm
delivery. A
cesarean section may be used to deliver the baby
quickly or to avoid the difficulty of
inducing labor before term. A moderately affected
newborn sometimes requires a blood transfusion immediately after
birth.
If testing shows that your fetus is severely affected by
your Rh factor antibodies, a
blood transfusion may be given before birth (intrauterine fetal blood transfusion). This can be
done through the fetus's abdomen or directly into the fetus's umbilical cord. A
preterm delivery is likely to be needed. Multiple blood transfusions are
sometimes necessary to keep a fetus healthy until the fetal lungs mature enough
to function after birth. Often a cesarean section is done to deliver the baby
quickly. A blood transfusion is sometimes necessary immediately after birth.
Prevention
If you are Rh-negative and pregnant
If you are an
Rh-negative woman and you have conceived with an
Rh-negative partner, you are not at risk of
Rh sensitization during pregnancy. (Most health
professionals treat all Rh-negative pregnant women as
though the father might be Rh-positive.)
If you are already sensitized to the Rh factor, your pregnancy
will need to be closely monitored to prevent fetal harm. For more information
on fetal and newborn treatment, see the Treatment Overview section of this
topic.
If you are unsensitized
Rh-negative, treatment focuses on preventing Rh sensitization during pregnancy
and childbirth.
Rh immune globulin (such as RhoGAM) is a highly effective treatment for
preventing sensitization.
To prevent sensitization from occurring late
in the pregnancy or during delivery, you must have a shot of Rh immune globulin
around week 28 of your pregnancy. This treatment prevents your immune system
from making
antibodies against your fetus's Rh-positive red blood
cells.
Rh immune globulin injection is also necessary if you have
had any vaginal bleeding or an obstetric procedure such as
amniocentesis or
external cephalic version.
If your newborn
is Rh-positive, you are given Rh immune globulin again within 72 hours of
delivery. By preventing Rh sensitization from delivery, you are protecting your
next Rh-positive fetus.
If your newborn is Rh-negative, sensitization cannot happen,
and no treatment is necessary.
Use of
Rh immune globulin is 99.8% effective in preventing
Rh sensitization.1 Rh
immune globulin contains Rh
antibodies that have been purified from human donors.
This treatment prevents an unsensitized Rh-negative mother from making
antibodies against her fetus's Rh-positive blood.
If an affected fetus younger than 34 weeks needs to be delivered,
corticosteroid medication (betamethasone or dexamethasone) may be given to the mother to speed fetal lung
development before a premature birth.
Surgery
There is no surgical treatment for
Rh sensitization during pregnancy.
American College of Obstetricians and Gynecologists
(ACOG)
409 12th Street SW
P.O. Box 96920
Washington, DC 20090-6920
Phone:
(202) 638-5577
E-mail:
resources@acog.org
Web Address:
www.acog.org
American College of Obstetricians and Gynecologists
(ACOG) is a nonprofit organization of professionals who provide health care for
women, including teens. The ACOG Resource Center publishes manuals and patient
education materials. The Web publications section of the site has patient
education pamphlets on many women's health topics, including reproductive
health, breast-feeding, violence, and quitting smoking.
American College of Obstetricians and Gynecologists
(1999). Prevention of Rh D alloimmunization. ACOG Practice Bulletin No. 4.
Obstetrics and Gynecology, 93(5):
1-7.
Hartwell EA (1998). Use of Rh immune globulin: ASCP
practice parameter. American Journal of Clinical Pathology, 110(3): 281-292.
Porter TF, et al. (2003). Immunologic disorders in
pregnancy. In JR Scott et al., eds., Danforth's Obstetrics and Gynecology, 9th ed., pp. 313-338. Philadelphia: Lippincott Williams and
Wilkins.
American College of Obstetricians and Gynecologists
(2006). Management of alloimunization during pregnancy. ACOG Practice Bulletin
No. 75. Obstetrics and Gynecology, 108(20):
457-464.
Other Works Consulted
Moise KJ Jr (2003). Management of rhesus
alloimmunization in pregnancy. Obstetrics and Gynecology, 100(3): 600-611.
Roman AS, Pernoll ML (2007). Rh isoimmunization and
other blood group incompatibilities section of Late pregnancy complications. In
AH DeCherney et al., eds., Current Diagnosis and Treatment Obstetrics and Gynecology, pp. 282-287. New York: McGraw-Hill.
Credits
Author
Kathe Gallagher, MSW
Editor
Kathleen M. Ariss, MS
Editor
Susan Van Houten, RN, BSN, MBA
Associate Editor
Tracy Landauer
Primary Medical Reviewer
Joy Melnikow, MD, MPH - Family Medicine
Specialist Medical Reviewer
Gregory A L Davies, MD, FRCSC, FACOG - Maternal-Fetal Medicine
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
American College of Obstetricians and Gynecologists
(1999). Prevention of Rh D alloimmunization. ACOG Practice Bulletin No. 4.
Obstetrics and Gynecology, 93(5):
1-7.
Hartwell EA (1998). Use of Rh immune globulin: ASCP
practice parameter. American Journal of Clinical Pathology, 110(3): 281-292.
Porter TF, et al. (2003). Immunologic disorders in
pregnancy. In JR Scott et al., eds., Danforth's Obstetrics and Gynecology, 9th ed., pp. 313-338. Philadelphia: Lippincott Williams and
Wilkins.
American College of Obstetricians and Gynecologists
(2006). Management of alloimunization during pregnancy. ACOG Practice Bulletin
No. 75. Obstetrics and Gynecology, 108(20):
457-464.